Abacus Global Management earnings date
Want to see ABX full AI Analyst Report?
Abacus Global Management (ABX) Q3 2026 Earnings Report
ABX Q3 2026 EPS Results
- Actual EPS
- $0.29
- Consensus EPS
- $0.28
- Beat/Miss
- Beat by +$0.01
- One Year Ago EPS
- $0.24
ABX Q3 2026 Revenue Results
- Actual Revenue
- $76.88M
- Expected Revenue
- $73.26M
- Beat/Miss
- Beat by +$3.62M
- YoY Revenue Growth
- +22.09%
Earnings Announcement Details
- Quarter
- Q3 2026
- Date
- 11/05/2026
- Time
- After Close
- Conference Call
- Thursday, November 5, 2026
Abacus Global Management's next earnings date is estimated for March 25, 2027, based on past reporting schedules.
Q3 2026 Earnings Call Audio
Q3 2026 Earnings Slide Deck
Q3 2026 Earnings Call Summary
The call was strongly positive. Abacus reported revenue, adjusted net income, adjusted EPS, capital deployment, fund inflows, cash conversion, realized gains, and portfolio turnover at strong levels, raised full-year guidance, completed a substantially oversubscribed record securitization, and described early LifeARC and partnership traction. The main challenges were higher operating and professional expenses, lower unrealized gains and asset management fees, the currently small share of fee-related revenue, distribution timing for certain fund platforms, and management's expectation that capital deployment growth will moderate. These lowlights were outweighed by the reported operating performance and strategic progress.
Management now expects full year 2026 adjusted net income of $104.5 million to $106.5 million and adjusted EPS of $1.05 to $1.07, with the top end representing 24% growth over 2025; for the fourth quarter, it expects adjusted net income of $28 million to $30 million and adjusted EPS of $0.28 to $0.30, with the top end representing 30% growth over the fourth quarter of 2025, and adjusted net income guidance is presented on a gross basis before estimated tax effects. Management expects to pursue 2 to 3 securitizations per year, with the next currently planned for the first quarter of 2027, and is targeting another 2 to 3 in 2027; it expects in Q1 to start to see some interesting flows into the ABX Longevity Growth and Income Fund, targets 70% fee-related revenue by 2030 versus about 11% today, recommends modeling average realized gains “a little more conservatively, in that 20% range,” and expects turnover to remain “slightly elevated,” “whether that dips below 1.5, but maybe towards the upper end of our 2x target.”
- Raised 2026 Guidance and Strong Quarterly EarningsThird-quarter adjusted net income was $29.4 million, above the previously guided range of $26 million to $28 million. Full-year 2026 adjusted net income guidance was raised to $104.5 million to $106.5 million from $100 million to $106 million, and adjusted EPS guidance was raised to $1.05 to $1.07 from $1 to $1.05. At the top end, the guidance represents 24% growth over 2025. Fourth-quarter adjusted net income is expected at $28 million to $30 million, with adjusted EPS of $0.28 to $0.30, representing 30% growth over the fourth quarter of 2025 at the top end.
- Revenue and Net Income GrowthThird-quarter revenue was $76.9 million, up 22% year-over-year. Adjusted net income grew 24% year-over-year to $29.4 million, and adjusted EPS was $0.29. Adjusted return on equity was 26%, up 440 basis points year-over-year.
- Life Solutions and Technology Services GrowthLife Solutions revenue was $71.3 million, up 32% from $54.1 million a year ago, while Technology Services revenue was $0.6 million, up 155% from $0.2 million. Growth in Life Solutions was driven by strong performance on life settlement policies sold: realized gains on policies sold and matured rose by $25.8 million year-over-year, more than offsetting an $11.1 million decline in unrealized gains. Insurance commissions increased 145.5% and originations increased 281.9% year-over-year.
- Strong Capital Deployment and Origination ActivityAbacus deployed $235.3 million of capital in the third quarter and $596.8 million year-to-date, up 71% compared with the 2025 pace. The company reviewed 17,787 qualified policies in the quarter and more than 101,000 year-to-date. Management said inbound volume, screening and underwriting efficiency, technology, and AI have improved.
- Longevity Fund Inflows AcceleratedLongevity fund inflows totaled approximately $452.4 million in the third quarter, more than 6x the rate of the prior-year period. Through the third quarter, longevity fund inflows were $997 million compared with $604 million for all of 2025.
- Cash Conversion Exceeded Adjusted EBITDACash EBITDA over the last 12 months was $203.2 million, or 132% of adjusted EBITDA, as gains recorded in prior periods converted to cash faster than new gains were added. Year-to-date, operating cash flow was $1.46 for every dollar of adjusted EBITDA.
- Independent Validation of Asset MarksTwo funds representing more than $1 billion in AUM sold 27% of their portfolios to investors above NAV. Management described independent buyers paying more than the carried values as a strong check on the company's marks.
- Record $400 Million-Plus SecuritizationThe September securitization totaled more than $400 million, making it Abacus's largest to date and roughly 8x the size of its inaugural $50 million note in October 2025. The investment-grade notes were placed primarily with insurance companies, and the transaction was 2x oversubscribed, allowing the company to upsize it.
- Expansion of Securitization Distribution ChannelManagement said securitization adds a lower-cost source of capital, supports faster capital recycling, creates recurring servicing and residual income, and opens access to insurance companies and other fixed-income buyers. Abacus expects to pursue 2 to 3 securitizations per year, with the next currently planned for the first quarter of 2027.
- Higher Portfolio Turnover and Realized GainsAnnualized portfolio turnover was 3x in the third quarter, above the long-term target of 1.5 to 2x. Capital deployment was up 130% year-over-year, and the average realized gain on policy sales was approximately 24%, above the long-term target of 20% plus. Policies sold during the quarter had an average holding period of approximately 62 days, compared with approximately 212 days for policies still on the balance sheet.
- Growing Servicing Platform and Channel EconomicsThe servicing platform covers 3,905 policies and $8 billion of face value. Management said institutional sales generate a one-time upfront gain, while longevity funds add 75 to 100 basis points of annual management and servicing fees plus performance fees, and securitizations add 50 to 100 basis points annually plus a retained residual targeted in the teens on an IRR basis. The company is shifting more origination toward funds and securitizations.
- LifeARC Early TractionLifeARC generated 357 inquiries to date. In the first week of the new client pipeline, inquiries represented roughly $43 million of combined investable assets, averaging about $7 million per inquiry, with the largest at $20 million. The pipeline has included more than $500 million of investable assets. Ninety-one percent of inquiries were from people age 50 or older, the average age was 66, and 100% opted to be contacted.
- LifeARC Partnership and Search MomentumSix of the first seven pipeline inquiries came through the lifespan calculator, and Abacus received its first referral flow from abacusgm.com into LifeARC. Retirable and Manning & Napier were live and enrolling clients into LifeARC investment portfolios. Since the October 13 partnership announcement, LifeARC held the number-one Google position for its name, while branded search clicks rose fivefold in one week.
- Manning & Napier Partnership Producing Multiple SynergiesManning & Napier, which has more than $18 billion in assets under management across its RIA and investment funds, is working with Abacus across policy sourcing, increased financial-advisory lead generation, and distribution of Abacus funds. Management said the partnership was already producing real dollar-amount impacts within a few months and that LifeARC would be rolled out within Manning & Napier.
- Balance Sheet and Shareholder ReturnsCash at quarter-end was $104 million, policy assets were $370 million, and management described the balance sheet as a strength supporting LifeARC, partnerships, and growth. The Board authorized a $100 million share repurchase program through May 2028; Abacus repurchased $1.7 million of stock during the quarter at an average price of $8.13. The Board also approved a 10% increase in the regular annual dividend to $0.22 per share.
- Strategic Progress Across the PlatformDuring the quarter, Abacus hosted Investor Day at the New York Stock Exchange, launched the ABX Longevity Growth and Income Fund, completed its largest securitization, and broadened LifeARC's reach through partnerships with Retirable and Manning & Napier. Management said more than 20 years of longevity data now supports both institutional capital markets and individual financial planning.
ABX Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Mar 25, 2027 | 2026 (Q4) | 0.29- | 0.23 | ― | ― |
| Nov 05, 2026 | 2026 (Q3) | 0.280.29 | 0.24 | 20.83% (+0.05) | |
| Aug 06, 2026 | 2026 (Q2) | 0.240.28 | 0.22 | 27.27% (+0.06) | |
| May 07, 2026 | 2026 (Q1) | 0.210.20 | 0.18 | 11.11% (+0.02) | |
| Mar 12, 2026 | 2025 (Q4) | 0.190.23 | 0.16 | 43.75% (+0.07) | |
| Nov 06, 2025 | 2025 (Q3) | 0.180.24 | 0.2 | 20.00% (+0.04) | |
| Aug 07, 2025 | 2025 (Q2) | 0.160.22 | 0.18 | 22.22% (+0.04) | |
| May 08, 2025 | 2025 (Q1) | 0.160.18 | 0.11 | 63.64% (+0.07) | |
| Mar 27, 2025 | 2024 (Q4) | 0.140.16 | -0.1 | 263.27% (+0.26) | |
| Nov 07, 2024 | 2024 (Q3) | 0.140.20 | 0.01 | 1328.57% (+0.19) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
